Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B J M Vlaminckx

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|January 9, 2008
[HIV should become a notifiable disease]B J M Vlaminckx, C A B Boucher
Nederlands Tijdschrift Voor Geneeskunde|September 15, 2006
[The Dutch MRSA policy should be retained]B J M Vlaminckx, A Troelstra, T van der Bruggen
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 22, 2005
Epidemiological considerations following long-term surveillance of invasive group A streptococcal disease in The Netherlands, 1992-2003B J M Vlaminckx, W van Pelt, J F P Schellekens
Nederlands Tijdschrift Voor Geneeskunde|August 30, 2007
[Invasive Lancefield group A streptococcal infections in the Netherlands]B J M Vlaminckx, E M Mascini, J F P Schellekens
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 28, 2017
Disagreement between the results from three commercial tests for the detection of Borrelia-specific serum antibodies in the Netherlands associated with antibiotic treatment for Lyme borreliosis: a retrospective studyT van Gorkom, K Kremer, W Voet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 31, 2006
Genes for the majority of group a streptococcal virulence factors and extracellular surface proteins do not confer an increased propensity to cause invasive diseaseDavid J McMillan, R G Beiko, R Geffers, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 18, 2005
Long-term surveillance of invasive group A streptococcal disease in The Netherlands, 1994-2003B J M Vlaminckx, W van Pelt, L M Schouls, et al.
Vaccine|August 14, 2017
Pneumococcal conjugate vaccination response in patients after community-acquired pneumonia, differences in patients with S. pneumoniae versus other pathogensG H J Wagenvoort, B J M Vlaminckx, D A van Kessel, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 2014
Bacteraemic and non-bacteraemic/urinary antigen-positive pneumococcal community-acquired pneumonia comparedS P van Mens, A M M van Deursen, S C de Greeff, et al.
Journal of Clinical Microbiology|January 26, 2018
An Enzyme-Linked Immunosorbent Spot Assay Measuring Borrelia burgdorferi B31-Specific Interferon Gamma-Secreting T Cells Cannot Discriminate Active Lyme Neuroborreliosis from Past Lyme Borreliosis: a Prospective Study in the NetherlandsT van Gorkom, S U C Sankatsing, W Voet, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Nederlands Tijdschrift Voor Geneeskunde|January 9, 2008
[HIV should become a notifiable disease]B J M Vlaminckx, C A B Boucher
Nederlands Tijdschrift Voor Geneeskunde|September 15, 2006
[The Dutch MRSA policy should be retained]B J M Vlaminckx, A Troelstra, T van der Bruggen
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 22, 2005
Epidemiological considerations following long-term surveillance of invasive group A streptococcal disease in The Netherlands, 1992-2003B J M Vlaminckx, W van Pelt, J F P Schellekens
Nederlands Tijdschrift Voor Geneeskunde|August 30, 2007
[Invasive Lancefield group A streptococcal infections in the Netherlands]B J M Vlaminckx, E M Mascini, J F P Schellekens
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 28, 2017
Disagreement between the results from three commercial tests for the detection of Borrelia-specific serum antibodies in the Netherlands associated with antibiotic treatment for Lyme borreliosis: a retrospective studyT van Gorkom, K Kremer, W Voet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 31, 2006
Genes for the majority of group a streptococcal virulence factors and extracellular surface proteins do not confer an increased propensity to cause invasive diseaseDavid J McMillan, R G Beiko, R Geffers, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 18, 2005
Long-term surveillance of invasive group A streptococcal disease in The Netherlands, 1994-2003B J M Vlaminckx, W van Pelt, L M Schouls, et al.
Vaccine|August 14, 2017
Pneumococcal conjugate vaccination response in patients after community-acquired pneumonia, differences in patients with S. pneumoniae versus other pathogensG H J Wagenvoort, B J M Vlaminckx, D A van Kessel, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 2014
Bacteraemic and non-bacteraemic/urinary antigen-positive pneumococcal community-acquired pneumonia comparedS P van Mens, A M M van Deursen, S C de Greeff, et al.
Journal of Clinical Microbiology|January 26, 2018
An Enzyme-Linked Immunosorbent Spot Assay Measuring Borrelia burgdorferi B31-Specific Interferon Gamma-Secreting T Cells Cannot Discriminate Active Lyme Neuroborreliosis from Past Lyme Borreliosis: a Prospective Study in the NetherlandsT van Gorkom, S U C Sankatsing, W Voet, et al.
Pageof 2